story of the week
Rituximab for Acetylcholine Receptor Antibody–Positive Generalized Myasthenia Gravis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study
Neurology 2021 Dec 02;[EPub Ahead of Print], RJ Nowak, CS Coffey, JM Goldstein, MM Dimachkie, M Benatar, JT Kissel, GI Wolfe, TM Burns, ML Freimer, S Nations, V Granit, AG Smith, DP Richman, E Ciafaloni, MT Al-Lozi, LA Sams, D Quan, E Ubogu, B Pearson, A Sharma, JW Yankey, L Uribe, M Shy, AA Amato, R Conwit, KC O'Connor, DA Hafler, ME Cudkowicz, RJ BarohnFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.